ADORA2A and in situ carcinoma: Zhu et al. further demonstrated that XYS mimics the effect of A2AR antagonists by downregulating the expression of p-ERK, NF-κB, and A2AR in CIS rats while enhancing Na+/K+-ATPase activity and ATP levels.